BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29534900)

  • 1. Does Prophylactic Radiation Therapy to Avoid Gynecomastia in Patients With Prostate Cancer Increase the Risk of Breast Cancer?
    Aksnessæther BY; Solberg A; Klepp OH; Myklebust TÅ; Skovlund E; Hoff SR; Vatten LJ; Lund JÅ
    Int J Radiat Oncol Biol Phys; 2018 May; 101(1):211-216. PubMed ID: 29534900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3.
    Widmark A; Fosså SD; Lundmo P; Damber JE; Vaage S; Damber L; Wiklund F; Klepp O
    Urology; 2003 Jan; 61(1):145-51. PubMed ID: 12559286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment strategies to prevent and reduce gynecomastia and/or breast pain caused by antiandrogen therapy for prostate cancer : Statement from the DEGRO working group prostate cancer.
    Ghadjar P; Aebersold DM; Albrecht C; Böhmer D; Flentje M; Ganswindt U; Höcht S; Hölscher T; Müller AC; Niehoff P; Pinkawa M; Sedlmayer F; Zips D; Wiegel T;
    Strahlenther Onkol; 2020 Jul; 196(7):589-597. PubMed ID: 32166452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of gynecomastia and breast pain caused by androgen deprivation therapy in prostate cancer: tamoxifen or radiotherapy?
    Viani GA; Bernardes da Silva LG; Stefano EJ
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e519-24. PubMed ID: 22704706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy.
    Di Lorenzo G; Perdonà S; De Placido S; D'Armiento M; Gallo A; Damiano R; Pingitore D; Gallo L; De Sio M; Autorino R
    J Urol; 2005 Dec; 174(6):2197-203. PubMed ID: 16280763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safety and tolerability of low-dose irradiation for the management of gynaecomastia caused by antiandrogen monotherapy.
    Dicker AP
    Lancet Oncol; 2003 Jan; 4(1):30-6. PubMed ID: 12517537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gynecomastia as a complication of hormonotherapy for prostate cancer: effect of prophylactic breast irradiation].
    Abdah-Bortnyak R; Bernstein Z; Ramon N; Zalman D; Shnaider J; Kuten A
    Harefuah; 2007 Feb; 146(2):126-8, 164-5. PubMed ID: 17352282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy for prevention and therapy of gynecomastia due to antiandrogen treatment in prostate cancer patients: a patterns-of-care study.
    Neu B; Sautter V; Momm F; Melcher U; Seegenschmiedt H; Micke O; Sautter-Bihl ML
    Strahlenther Onkol; 2011 Dec; 187(12):771-7. PubMed ID: 22127363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of male breast cancer in association with bicalutamide-induced gynaecomastia.
    Chianakwalam CI; McCahy P; Griffiths NJ
    Breast; 2005 Apr; 14(2):163-4. PubMed ID: 15767188
    [No Abstract]   [Full Text] [Related]  

  • 10. Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10 Gy) significantly reduces the incidence of bicalutamide-induced gynecomastia.
    Tyrrell CJ; Payne H; Tammela TL; Bakke A; Lodding P; Goedhals L; Van Erps P; Boon T; Van De Beek C; Andersson SO; Morris T; Carroll K
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):476-83. PubMed ID: 15380582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and management of gynecomastia in men treated for prostate cancer.
    Dobs A; Darkes MJ
    J Urol; 2005 Nov; 174(5):1737-42. PubMed ID: 16217274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gynecomastia due to hormone therapy for advanced prostate cancer: a report of ten surgically treated cases and a review of treatment options.
    Prezioso D; Piccirillo G; Galasso R; Altieri V; Mirone V; Lotti T
    Tumori; 2004; 90(4):410-5. PubMed ID: 15510985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can prophylactic breast irradiation contribute to cardiac toxicity in patients with prostate cancer receiving androgen suppressing drugs?
    Nieder C; Pawinski A; Andratschke NH; Molls M
    Radiat Oncol; 2008 Jan; 3():2. PubMed ID: 18186924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy for prevention or management of gynecomastia recurrence: Future role for general gynecomastia patients in plastic surgery given current role in management of high-risk prostate cancer patients on anti-androgenic therapy.
    Safran T; Abi-Rafeh J; Alabdulkarim A; Roberge D; Luc M
    J Plast Reconstr Aesthet Surg; 2021 Nov; 74(11):3128-3140. PubMed ID: 34001449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does prophylactic breast irradiation in patients with prostate cancer influence cardiac toxicity?
    Nieder C; Pawinski A; Andratschke NH; Molls M
    J Natl Cancer Inst; 2007 Nov; 99(21):1646-7. PubMed ID: 17971531
    [No Abstract]   [Full Text] [Related]  

  • 16. Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study.
    Fradet Y; Egerdie B; Andersen M; Tammela TL; Nachabe M; Armstrong J; Morris T; Navani S
    Eur Urol; 2007 Jul; 52(1):106-14. PubMed ID: 17270340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic Breast Irradiation for Prevention of Bicalutamide-induced Painful Gynecomastia in Patients with Low- and Intermediate-risk Prostate Cancer.
    Chernomordikov E; Rouvinov K; Mermershtain W; Lavrenkov K
    Isr Med Assoc J; 2023 Mar; 25(3):205-209. PubMed ID: 36946666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is prophylactic breast radiotherapy necessary in all patients with prostate cancer and gynecomastia and/or breast pain?
    Ozen H; Akyol F; Toktas G; Eskicorapci S; Unluer E; Kuyumcuoglu U; Abay E; Cureklibatur I; Sengoz M; Yalcin V; Akpinar H; Zorlu F; Sengor F; Karaman I
    J Urol; 2010 Aug; 184(2):519-24. PubMed ID: 20620411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of gynecomastia in patients with prostate cancer and androgen deprivation.
    Bautista-Vidal C; Barnoiu O; García-Galisteo E; Gómez-Lechuga P; Baena-González V
    Actas Urol Esp; 2014; 38(1):34-40. PubMed ID: 23850393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: a systematic review.
    Kunath F; Keck B; Antes G; Wullich B; Meerpohl JJ
    BMC Med; 2012 Aug; 10():96. PubMed ID: 22925442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.